O'Shaughnessy Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $15.3M | Sell |
34,259
-1,341
| -4% | -$597K | 0.1% | 225 |
|
2025
Q1 | $17.3M | Buy |
35,600
+6,446
| +22% | +$3.13M | 0.14% | 171 |
|
2024
Q4 | $11.7M | Buy |
29,154
+472
| +2% | +$190K | 0.1% | 211 |
|
2024
Q3 | $13.9M | Buy |
28,682
+4,287
| +18% | +$2.08M | 0.12% | 184 |
|
2024
Q2 | $11.4M | Buy |
24,395
+4,697
| +24% | +$2.2M | 0.12% | 190 |
|
2024
Q1 | $8.23M | Buy |
19,698
+3,629
| +23% | +$1.52M | 0.09% | 256 |
|
2023
Q4 | $6.54M | Buy |
16,069
+2,761
| +21% | +$1.12M | 0.09% | 260 |
|
2023
Q3 | $4.63M | Buy |
13,308
+3,246
| +32% | +$1.13M | 0.07% | 300 |
|
2023
Q2 | $3.54M | Buy |
10,062
+2,296
| +30% | +$808K | 0.05% | 336 |
|
2023
Q1 | $2.45M | Sell |
7,766
-710
| -8% | -$224K | 0.04% | 405 |
|
2022
Q4 | $2.45M | Buy |
8,476
+490
| +6% | +$142K | 0.04% | 389 |
|
2022
Q3 | $2.31M | Buy |
7,986
+2,524
| +46% | +$731K | 0.04% | 371 |
|
2022
Q2 | $1.54M | Buy |
5,462
+2,239
| +69% | +$631K | 0.03% | 443 |
|
2022
Q1 | $841K | Buy |
3,223
+1,722
| +115% | +$449K | 0.01% | 573 |
|
2021
Q4 | $330K | Buy |
1,501
+498
| +50% | +$109K | 0.01% | 834 |
|
2021
Q3 | $182K | Buy |
1,003
+78
| +8% | +$14.2K | ﹤0.01% | 1089 |
|
2021
Q2 | $187K | Sell |
925
-396
| -30% | -$80.1K | ﹤0.01% | 1061 |
|
2021
Q1 | $284K | Sell |
1,321
-416
| -24% | -$89.4K | 0.01% | 793 |
|
2020
Q4 | $411K | Sell |
1,737
-382
| -18% | -$90.4K | 0.01% | 577 |
|
2020
Q3 | $577K | Buy |
2,119
+305
| +17% | +$83.1K | 0.02% | 415 |
|
2020
Q2 | $527K | Buy |
1,814
+1,559
| +611% | +$453K | 0.02% | 389 |
|
2020
Q1 | $61K | Sell |
255
-239
| -48% | -$57.2K | ﹤0.01% | 738 |
|
2019
Q4 | $108K | Buy |
494
+493
| +49,300% | +$108K | ﹤0.01% | 776 |
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1263 |
|
2019
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1232 |
|